Skyhawk Therapeutics

Drug Discovery
Data updated Nov 22, 2026Full reportReport a mistake

Facts

as of Nov 22, 2026

Skyhawk Therapeutics is a biotechnology company developing medicines and running clinical development programs. Its job ads cover clinical trial associates, clinical scientists and senior statistical programming directors in clinical operations. The company is headquartered in Waltham, Massachusetts, United States, with an office in Basel, Switzerland.

It is hiring: 2 open roles, 0 of them posted in the last 30 days.

Headquarters
Waltham, United States
Founded
2016
Employees
50US Form 5500 (plan participants) · Dec 2025 · +85% in a year
Open roles
2Alion job postings

As of Nov 22, 2026, Alion lists 2 open roles at Skyhawk Therapeutics. Skyhawk Therapeutics is headquartered in Waltham, United States. It was founded in 2016.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

Funds reporting to the SEC (3) valued their Skyhawk Therapeutics stock at $51.3M as of May 2026.

Fund marksPrice a share in fund marks, by quarter
May 2026$53.14sec.gov ↗
Feb 2026$55.51sec.gov ↗
Nov 2025$14.46sec.gov ↗
Aug 2025$12.81sec.gov ↗
Marks by fund: shares held, the price a share, the change since the last quarterPremiumUnlockor this company alone for 30 days · 50 credits
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".

2 open roles, 0 of them posted in the last 30 days.

2Open roles
50EmployeesUS Form 5500 (plan participants) · Dec 2025 · +85% in a year
Head countas filed and stated
Where the openings areshare of open roles
Biotech67%▼
Sales33%▼
Open roles over time
Sep 7This week
Open roles a week: 2 then, 2 now
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family

Products

Products →

Skyhawk Therapeutics has 3 clinical trials on record, 3 under way.

top 74%Web presenceof 133.2M domains by links, Common Crawl
Clinical trials
An Extension of SKY-0515 in Participants With Huntington's Disease
phase 3 · under way · 500 participants · Huntington's Disease (HD)
Apr 2026
Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease
phase 3 · under way · 400 participants · Huntington Disease
Jan 2026
Study of SKY-0515 for Safety, Efficacy, and Pharmacodynamics in Participants With Huntington's Disease
phase 3 · under way · 120 participants · Huntington Disease; Huntingtons Disease
May 2025
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.

Skyhawk Therapeutics: $30k of EU lobbying in 2025.

Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
US lobbying
2025 · FGS Global LLC $30,000
$30k
Patents
1
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
WalthamBusiest site
Loading the map
SiteTypeOpen rolesHires most forEngineering
Waltham United StatesHeadquarters2Biotech0%
Basel SwitzerlandRegional office0
Source: office addresses in postings and company registers

Ranked #9 by open roles among its 11 closest peers.

#CompanyHQOpen rolesSize
1Beeline MedicinesStamford, United States2451-200
2KymeraTxWatertown, United States1951-200
3City TherapeuticsCambridge, United States1351-200
4Wave Life SciencesCambridge, United States12201-500
9Skyhawk TherapeuticsWaltham, United States251-200
4 more records: closest peers with their size and open rolesProUnlockor this company alone for 30 days · 50 credits
Source: Alion's similar-companies engine (industry segments, technologies, headquarters country, size)

Tech stack

Technologies named in job postings at Skyhawk Therapeutics over the last 12 months, by layer, with the share of postings for each.

5Technologies in use
4Postings analysed
51/100Stack modernity
LanguagesSAS
Cloud & platformsGCP
Developer toolsVeeva
Practices & domainsGood Clinical PracticeCAPA
Sign in to see how your skills match this stackSign In
Source: the technologies named in the company's postings and on its site

Newsroom

top 74%Web presenceof 133.2M domains by links, Common Crawl
Sources: the outlets named on each headline, each story once